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A B S T R A C T   
Background: Air pollution has been suggested as a risk factor for chronic obstructive pulmonary disease (COPD), 
but evidence is sparse and inconsistent. 
Objectives: We examined the association between long-term exposure to low-level air pollution and COPD 
incidence. 
Methods: Within the ‘Effects of Low-Level Air Pollution: A Study in Europe’ (ELAPSE) study, we pooled data from 
three cohorts, from Denmark and Sweden, with information on COPD hospital discharge diagnoses. Hybrid land 
use regression models were used to estimate annual mean concentrations of particulate matter with a diameter <
2.5 µm (PM2.5), nitrogen dioxide (NO2), and black carbon (BC) in 2010 at participants’ baseline residential 
addresses, which were analysed in relation to COPD incidence using Cox proportional hazards models. 
Results: Of 98,058 participants, 4,928 developed COPD during 16.6 years mean follow-up. The adjusted hazard 
ratios (HRs) and 95% confidence intervals for associations with COPD incidence were 1.17 (1.06, 1.29) per 5 µg/ 
m3 for PM2.5, 1.11 (1.06, 1.16) per 10 µg/m3 for NO2, and 1.11 (1.06, 1.15) per 0.5 10− 5m− 1 for BC. Associations 
persisted in subset participants with PM2.5 or NO2 levels below current EU and US limit values and WHO 
guidelines, with no evidence for a threshold. HRs for NO2 and BC remained unchanged in two-pollutant models 
with PM2.5, whereas the HR for PM2.5 was attenuated to unity with NO2 or BC. 
Conclusions: Long-term exposure to low-level air pollution is associated with the development of COPD, even 
below current EU and US limit values and possibly WHO guidelines. Traffic-related pollutants NO2 and BC may 
be the most relevant.   
1. Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a common 
chronic respiratory disease characterized by progressive irreversible 
airflow limitation related to chronic inflammation in the lung paren-
chyma (Mannino and Buist, 2007). COPD is a complex disease deter-
mined by interactions between genetic and environmental factors, with 
smoking as the most important risk factor (Vijayan, 2013). Still, 
approximately 25–45% of COPD cases occur in never-smokers (Salvi and 
Barnes, 2009), and other risk factors, such as air pollution, are 
increasingly believed to play important roles (Eisner et al., 2010). 
Ambient air pollution is a major risk factor for mortality and 
morbidity. Globally, around 7.5% of total deaths were attributed to 
particulate matter with diameter < 2.5 µm (PM2.5) in 2016 (GBD 2016 
Risk Factors Collaborators, 2017). Although it is well accepted that air 
pollution exposure is linked to airway disease (Kelly and Fussell, 2011), 
direct epidemiological and mechanistic evidence linking long-term air 
pollution exposure to COPD onset is sparse and insufficient, as 
concluded by an official report by American Thoracic Society (Thurston 
et al., 2020). We provide detailed information on previous epidemio-
logical studies in supplementary Table S1. Seven out of ten studies on 
long-term exposure to air pollution and COPD incidence documented 
positive associations with at least one pollutant under investigation 
(Andersen et al., 2011; Atkinson et al., 2015; Danesh Yazdi et al., 2019; 
Gan et al., 2013; Guo et al., 2018; Schikowski et al., 2014; Weichenthal 
et al., 2017), and three reported null associations with all pollutants 
under study (Carey et al., 2016; Fisher et al., 2016; Salimi et al., 2018). 
Some studies lack adjustment for the most relevant confounders, such as 
smoking (Danesh Yazdi et al., 2019; Gan et al., 2013; Weichenthal et al., 
2017). Additionally, only few studies explored the shape of the con-
centration response curve between long-term exposure to air pollution 
and COPD incidence (Danesh Yazdi et al., 2019; Gan et al., 2013; Guo 
et al., 2018), or presented mutually adjusted associations in two 
pollutant models (Atkinson et al., 2015; Carey et al., 2016; Gan et al., 
2013; Weichenthal et al., 2017). Several studies investigated the asso-
ciations of long-term air pollution exposure with lung function in adults 
(Guo et al., 2018; Lepeule et al., 2014; Rice et al., 2015; Wang et al., 
2019), which is a main feature of COPD development. 
The decrease in ambient air pollution level in Europe calls for new 
epidemiological studies to examine the health effects of air pollution at 
low levels, below current EU and US limit values or WHO guidelines 
(EEA, 2019). The ‘Effects of Low-Level Air Pollution: A Study in Europe’ 
(ELAPSE) project, which pooled data from 11 European cohorts with 
detailed individual information and seven large nationwide cohorts 
across Europe (http://www.elapseproject.eu/), was conducted to 
investigate the health effects of long-term exposure to low-level ambient 
air pollution among adults. 
Within the ELAPSE project, we aimed to investigate the associations 
of long-term exposures to PM2.5, nitrogen dioxide (NO2), black carbon 
(BC), and ozone (O3) and the development of COPD, particularly below 
current EU and US limit values and WHO guidelines. We further assessed 
the concentration response relationships and estimated the mutually 
adjusted associations. 
2. Methods 
2.1. Study population 
We used data from three cohorts within the ELAPSE project with 
available information on COPD hospital discharge diagnoses: 1) the 
Swedish Cardiovascular Effects of Air Pollution and Noise (CEANS) 
study (Beelen et al., 2014; Korek et al., 2015), which pooled data from 
four sub-cohorts: the Stockholm Diabetes Prevention Program (SDPP), 
the Stockholm Cohort of 60-year-olds (SIXTY), the Stockholm Screening 
Across the Lifespan Twin study (SALT), and the Swedish National Study 
on Aging and Care in Kungsholmen (SNAC-K); 2) the Danish Diet, 
Cancer and Health (DCH) study (Tjønneland et al., 2007); and 3) the 
Danish Nurse Cohort (DNC) study with two sub-cohorts from baseline 
rounds in 1993 and 1999 (Hundrup et al., 2012). Covariate data were 
collected by questionnaires at the cohort baseline, between 1992 and 
2004. More detail information on these cohorts are in online supplement 
S1 and Table S2. The study was undertaken in accordance with the 
Declaration of Helsinki. All three cohorts were approved by the local 
ethics committees in accordance with the national regulations. 
2.2. Exposure assessment 
Annual mean concentrations of PM2.5, NO2, BC, and warm season O3 
(April to September) for 2010 were estimated at the study participants’ 
baseline residential addresses, at a 100 × 100 m spatial resolution, using 
standardized Europe-wide hybrid land use regression (LUR) models (de 
Hoogh et al., 2018). The LUR model utilized routine monitoring data 
from the European Environment Agency (EEA) AirBase for PM2.5, NO2, 
and O3, and ESCAPE monitoring data for BC as the dependent variable. 
BC was measured by the reflectance of PM2.5 filters and expressed in 
absorbance units. The mean concentrations of O3 were estimated as the 
average of daily maximum 8-hour means. Satellite data, dispersion 
model estimates, land use, and traffic variables were predictors to 
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develop models to estimate annual mean air pollution concentrations. 
The models performed well in five-fold hold-out validation explaining 
72%, 59%, 54%, and 69% of spatial variability of the measured con-
centrations for PM2.5, NO2, BC, and O3, respectively (de Hoogh et al., 
2018). Predictions from the 2010 model correlated highly with models 
developed for 2000 and 2005 models for (NO2 and O3) and 2013 model 
for PM2.5 at the overall European scale, with squared correlations (R2) 
larger than 76% (de Hoogh et al., 2018). 
Additionally, we estimated pollutant concentrations for each year 
from baseline to the end of follow-up using back-extrapolation to 1990. 
We applied back-extrapolation by using monthly average concentrations 
from a chemical transport and dispersion model based on emission and 
meteorological data, the Danish Eulerian Hemispheric Model (DEHM), 
across Europe at 26 × 26 km spatial resolution back to at least 1990 
(Brandt et al., 2012). The rationale to use DEHM for back-extrapolation 
is the consistent availability of estimates across Europe for the full study 
period for all pollutants. In contrast, routine AirBase monitoring data 
were less consistent, not available for BC and only available from about 
2008 for PM2.5, which does not give us a solid base to perform a 
harmonious back-extrapolation across cohort areas. Residential history 
addresses for each year of follow-up were incorporated in the back- 
extrapolation, such that both changes in air pollution spatial patterns 
and moving residential address were accounted for. For application to 
the cohorts, we calculated population-weighted average concentrations 
at the NUTS-1 spatial scale (Nomenclature of territorial units for sta-
tistics), allowing different spatial trends within Europe. The NUTS 
classification is a hierarchical system for dividing up the economic ter-
ritory of the EU and the UK for the purpose of the collection, develop-
ment and harmonization of European regional statistics. NUTS 1 reflect 
major socio-economic regions and may be an entire (small) country or 
parts of a country (e.g. four regions in the Netherlands and 14 regions in 
France). We compared temporal patterns of predicted DEHM and 
measured AirBase concentrations for countries (Sweden were not 
included) with available measurements, and trends are fairly similar for 
modeled and measured data, better for NO2 than for PM2.5 (data not 
shown). 
For our study based on three cohorts in Denmark and Sweden within 
ELAPSE project, we back-extrapolated concentrations for all pollutants 
for CEANS and DCH cohorts with available historical address informa-
tion, using both an absolute difference and a ratio method with 2010 as 
the reference year. With the absolute difference method, the concen-
tration difference between a year and 2010 from the DEHM model is 
added to all cohort exposures for that year in the same NUTS-1 area. 
With the ratio method, the concentration ratio between a year and 2010 
from the DEHM model is used to multiply all cohort exposure for that 
year in the same NUTS-1 area. In case of higher concentrations in the 
past, the ratio method therefore increases the contrast in cohort 
exposures. 
2.3. Outcome definition 
We defined incidence of COPD as the first-ever hospital discharge 
diagnosis for COPD after baseline, which was defined as emergency 
room visits, inpatient hospitalizations, or outpatient visits in the Danish 
cohorts (DCH and DNC), and inpatient hospitalization in CEANS, 
following the principal diagnosis of International Classification of Dis-
eases, 9th Revision (ICD-9) codes 490–492, and 494–496, or ICD-10 
codes J40–44. 
2.4. Statistical analysis 
We used stratified Cox proportional hazards models, to examine the 
associations of long-term exposure to air pollution with COPD incidence, 
with censoring at the time of death, diagnosis of asthma (principal 
diagnosis of ICD-9 codes 493 or ICD-10 codes J45-46), emigration, or 
the end of follow-up in 2011 (CEANS) or 2015 (DCH and DNC), 
whichever came first. Air pollution exposure was entered first as a linear 
term. Age was the underlying time scale due to the evidence of better 
adjustment for potential confounders by age (Thiebaut and Benichou, 
2004). The associations between air pollutants and COPD were exam-
ined using three models with an increasing level of adjustment for a 
priori defined individual- and area-level confounders. Model 1 included 
age (time axis), sex (strata), sub-cohort (strata), and the cohort baseline 
year (1992–2004). Model 2 additionally adjusted for smoking status 
(never, former, current), smoking duration (years), smoking intensity 
(linear and squared term; cigarettes/day), body-mass index (BMI, cate-
gorical: <18.5, 18.5–24.9, 25.0–29.9, ≥30 kg/m2), marital status (sin-
gle, married/living with partner, divorced, widowed), employment 
status (employed, other), and educational level (primary school or less, 
secondary school, university degree or more). Model 3 (main model), 
additionally adjusted for area-level annual year income (in euros): at 
municipality-level in 2001 for DCH and DNC, and at neighbourhood 
level in 1994 for CEANS. Participants with complete information for all 
variables in Model 3 were included in the analyses, and participants with 
COPD hospital diagnoses before baseline were excluded. 
We examined whether associations persisted at low concentrations 
by excluding participants with exposure to a priori defined cut-off 
values, including existing EU and US limit values and WHO guidelines 
(25, 20, 15, 12, 10 µg/m3 for PM2.5; 40, 30, 20 µg/m3 for NO2; 3, 2.5, 2, 
1.5, 1, 0.5 10− 5m− 1 for BC; and 80, 60 µg/m3 for O3). To further evaluate 
the shape of the concentration response curves between air pollution 
exposure and COPD incidence, we used natural cubic splines with three 
degrees of freedom in Model 3 and tested for the deviation of linearity 
from the linear model using likelihood ration test. In an attempt to ac-
count for mutual correlation and estimate independent effect of each 
pollutant on COPD development, we fitted two-pollutant models in 
Model 3 and did collinearity test for pollutants. 
We conducted several sensitivity analyses. First, to examine the 
robustness of using 2010 as the reference year for air pollution exposure 
assignment, we re-ran Model 3 with 1) back-extrapolated annual 
average concentrations in baseline year, using the difference and ratio 
between 2010 and the baseline year; 2) time-varying air pollution 
concentrations, using back-extrapolated annual averages for cohorts 
with complete residential history addresses from baseline until the end 
of follow-up (available for CEANS, DCH), with 1-year or 5-year strata to 
account for time trends in COPD incidence and air pollution. Secondly, 
we estimated associations in Model 3 by separately including each of the 
three cohorts or by excluding one cohort each time. 
We assessed potential effect modification of the association between 
air pollution and COPD incidence by age at baseline (<65, ≥65 years), 
BMI, smoking status, marital status, employment status, educational 
level, and asthma status at baseline, by introducing an interaction term 
into Model 3 and using the Wald test. 
The results are presented as hazard ratios (HRs) and 95% confidence 
intervals (CIs) for an increase of 5 µg/m3 for PM2.5, 10 µg/m3 for NO2, 
0.5 10− 5 m− 1 for BC, and 10 µg/m3 for O3. All analyses were performed 
in R software (version 3.4.0). 
3. Results 
From a total of 106,727 participants with complete air pollution 
exposure data (21,986 from CEANS, 56,308 from DCH, and 28,433 from 
DNC), we excluded 633 participants with COPD at baseline and 7,586 
participants with missing information on confounders. Of the remaining 
98,508 participants in the main analyses, recruited between 1992 and 
2004 (cohort baseline), 4,928 developed COPD during a mean follow-up 
of 16.6 years (Table 1). Mean age at baseline was 55.8 years. Partici-
pants who developed COPD were older, less likely to be married, 
employed, or highly educated, smoked more, and had higher levels of 
PM2.5, NO2, and BC compared to those without COPD. 667 (1%) par-
ticipants were asthma patients at baseline and 180 developed COPD 
during follow-up (Table 1). More details on cohorts and sub-cohorts are 
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in supplementary Table S2. 
Mean air pollution levels in 2010 were 12.1 μg/m3 for PM2.5, 25.1 
µg/m3 for NO2, 1.2 10− 5m− 1 for BC, and 78.1 μg/m3 for O3 (Table 1). In 
all three cohorts, some participants exceeded the EU limit value and the 
WHO guideline of 40 µg/m3 for NO2, while all participants complied 
with the EU limit value for PM2.5 of 25 µg/m3, and the PM2.5 levels in 
CEANS complied even with the WHO guideline of 10 µg/m3 (Fig. 1 and 
Table S3). We observed that air pollution levels were decreasing during 
follow-up time (Figure S1). The Pearson correlation coefficients were 
strongest between BC and NO2 (overall r = 0.91, ranging 0.43–0.93 by 
sub-cohorts), followed by BC and PM2.5 (overall r = 0.74, ranging 
0.29–0.70 by sub-cohorts). PM2.5 was moderately correlated with NO2 
(overall r = 0.63, ranging 0.60–0.75 by sub-cohorts), while O3 was 
negatively correlated with all other pollutants (Table S4). 
In single-pollutant models (Table 2), long-term exposures to PM2.5, 
NO2, and BC were positively associated with COPD incidence in all three 
models, with substantial reduction in HR from Model 1 to Model 2 
(mainly explained by smoking), and no change in estimates from Model 
2 to Model 3. The fully adjusted HRs (95% CIs) in Model 3 were 1.17 
(1.06, 1.29) per 5 µg/m3 increase for PM2.5, 1.11 (1.06, 1.16) per 10 µg/ 
m3 increase for NO2, 1.11 (1.06, 1.15) per 0.5 10− 5m− 1 increase for BC, 
and 0.99 (0.93, 1.05) per 10 µg/m3 increase for O3. 
In two-pollutant models (Table 2), the HRs for NO2 and BC remained 
unchanged from single-pollutant models after adjusting for PM2.5 and 
were somewhat higher after adjustment for O3, whereas the HR for 
PM2.5 was attenuated to unity after adjusting for either NO2 or BC. For 
NO2 and BC, the HRs for NO2 and BC were attenuated slightly and 
changed to non-significant after adjusting for each other. However, 
because of the high correlation between NO2 and BC, it was difficult to 
interpret this two-pollutant model even though no collinearity was 
detected for the two pollutants in two-pollutant model [variance infla-
tion factors (VIFs) are around 6]. In two-pollutant models with O3, the 
HRs for PM2.5, NO2, or BC were essentially unaffected, while the nega-
tive association between O3 and COPD incidence changed to positive 
after adjustment for PM2.5, NO2, or BC, partially explained by the 
negative correlations for O3 with other pollutants (Table S4). 
The HRs were generally higher in sub-populations with lower air 
pollution levels, with slightly larger CIs (Table 3). There was no signif-
icant deviation from linearity for any pollutants except for NO2 (p =
0.04). The concentration response curves showed linear associations at 
concentrations between 5th and 95th percentiles (green lines in the 
Fig. 2) for PM2.5, NO2, and BC, with somewhat steeper curves at the 
lowest levels, levelling off at higher levels, with no evidence of a 
threshold (Fig. 2). 
Associations for PM2.5 were attenuated to unity when using back- 
extrapolated exposure at baseline with both ratio and difference 
methods, and were only slightly attenuated (ratio method) or remained 
unchanged (difference method) for NO2 and BC exposures (Table S5). 
Observed associations were robust to applying time-varying exposure 
analyses (Figure S2 and Table S6) or restricting participants to subsets of 
cohorts (Table S7). In effect modification analyses (Figure S3), the as-
sociations of PM2.5 were consistently stronger in participants aged < 65 
years, obese participants, current smokers, married/divorced partici-
pants, and people with low education, with significant interaction 
though observed only for PM2.5 with age, as well as PM2.5, NO2, and BC 
with marital status. We did not find any significant modification by 
asthma status at baseline, with significant positive associations in nurses 
without asthma and positive associations but with very wide CIs in 
nurses with asthma (small population of 667 nurses with asthma). 
4. Discussion 
In this analysis of 98,508 adults from Denmark and Sweden, we 
observed that long-term exposures to PM2.5, NO2, and BC were associ-
ated with increased risks of COPD, even at levels below current EU and 
US limit values and possibly WHO guidelines. The concentration 
response curves and subset analyses showed no evidence of a threshold. 
PM2.5 was not associated with COPD in two-pollutant models with 
adjustment for NO2 or BC, while associations with NO2 and BC remained 
robust after adjusting for PM2.5. The robust associations with NO2 and 
BC might reflect direct effects of NO2 or correlated particles emitted 
from combustion sources, such as BC and ultrafine particles (UFPs; 
particulate matter with diameter < 0.1 µm). 
Our results are in line with findings from several studies on long-term 
exposure to air pollution and COPD incidence (Andersen et al., 2011; 
Atkinson et al., 2015; Danesh Yazdi et al., 2019; Gan et al., 2013; Guo 
et al., 2018; Schikowski et al., et al., 2014; Weichenthal et al., 2017). In a 
study of 11,084,660 Medicare beneficiaries, Danesh Yazdi et al. linked 
long-term exposure to PM2.5 with first hospital admission for COPD with 
a HR of 1.051 (1.050–1.052) per 1 μg/m3, which persisted in a subset of 
cohort with PM2.5 values below 12 μg/m3, the US limit value (Danesh 
Yazdi et al., 2019). In a cohort of 91,709 participants from Taiwan, Guo 
et al. reported a significant association of PM2.5 with COPD with a HR of 
1.08 (1.04–1.11) per 5 μg/m3 (Guo et al., 2018). However, neither of 
these studies had data on NO2 and BC and could not evaluate whether 
the association with PM2.5 was confounded by these two pollutants, as 
Table 1 
Characteristics of participants at baseline and residential air pollutants for the 
year 2010 by first-ever COPD hospitalization status.  
Characteristic Total (N =
98,508) 
No COPD (N =
93,580) 
COPD (N =
4,928) 
Population    
Baseline period, years 1992–2004 — — 
End of follow-up, years 2011, 2015 — — 
Person-years at risk, 
person years 
1,637,916 1,584,771 53,145 
Follow-up time, years 
(mean ± SD) 
16.6 ± 4.7 16.9 ± 4.9 10.8 ± 5.8 
Age, years (mean ± SD) 55.8 ± 7.5 55.6 ± 7.5 58.3 ± 5.9 
Age < 65 years old, n (%) 91,529 (93) 86,983 (93) 4,546 (92)  
Individual level 
variables#    
Female, n (%) 64,689 (66) 61,563 (66) 3,126 (63) 
BMI, kg/m2 (mean ± SD) 25.3 ± 4.0 25.3 ± 4.0 25.3 ± 4.4 
Normal weight, n (%) 50,004 (51) 47,549 (51) 2,455 (50) 
Smoking duration, years 
(mean ± SD) 
17.0 ± 16.5 16.2 ± 16.2 33.2 ± 13.3 
Smoking intensity, n/day 
(mean ± SD) 
9.2 ± 10.4 8.8 ± 10.2 16.2 ± 10.5 
Never smoker, n (%) 36,571 (37) 36,173 (39) 398 (8) 
Married or living with 
partner, n (%) 
70,287 (71) 67,264 (72) 3,023 (61) 
Employed, n (%) 75,323 (76) 72,202 (77) 3,121 (63) 
High educational level, n 
(%) 
43,435 (44) 41,785 (45) 1,650 (33) 
Asthma patients, n (%) 667 (1) 487 (1) 180 (4)  
Area-level variable    
Mean year income, €ϕ 20990.9 21046.1 19942.2  
Air pollutants*    
PM2.5, µg/m3 (mean ± SD) 12.12 ± 2.48 12.07 ± 2.50 13.04 ± 1.86 
NO2, µg/m3 (mean ± SD) 25.11 ± 7.97 24.98 ± 7.97 27.53 ± 7.51 
BC, 10− 5m− 1 (mean ± SD) 1.17 ± 0.41 1.17 ± 0.41 1.32 ± 0.38 
O3, µg/m3 (mean ± SD) 78.13 ± 4.62 78.17 ± 4.59 77.41 ± 5.07 
BMI: body mass index; SD: standard deviation; SES: socio-economic status; 
COPD: chronic obstructive pulmonary disease; PM2.5: particulate matters with 
aerodynamic diameters of <2.5 μm; NO2: nitrogen dioxide; BC: black carbon; 
O3: ozone. 
*: The annual average concentrations of PM2.5, NO2, BC, and O3 were estimated 
for the year 2010 at 100 m resolution. O3 was estimated during the warm season 
from April 1 through September 30. 
#: Normal weight means BMI values from 18.5 to 24.9 according to the World 
Health Organization (WHO) categories; High education level means university 
degree and more. 
ϕ: Mean year income is a continuous variable in euros, which is at municipality- 
level in 2001 for DCH and DNC and at neighbourhood level in 1994 for CEANS. 
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observed in our study. In a Canadian cohort of 1.1 million Toronto 
residents, Weichenthal et al. reported significant associations of COPD 
with both PM2.5 and NO2, with HRs of 1.06 (1.04–1.08) per 3.2 μg/m3 
and 1.11 (1.07–1.15) per 4.1 ppb, respectively, which persisted in 
mutually adjusted model (Weichenthal et al., 2017). Andersen et al. 
reported an association between NO2 and first hospital diagnosis for 
COPD in the DCH cohort, with a HR of 1.08 (1.02–1.14) per 5.8 μg/m3, 
but with no data on PM2.5 or BC (Andersen et al., 2011). However, the 
two large cohorts from US and Canada did not adjust for smoking habits, 
which is an important confounder of an association between air pollu-
tion and COPD (Danesh Yazdi et al., 2019; Weichenthal et al., 2017). 
Additionally, three other studies, Gan et al. in a Canadian study of 
467,994 Vancouver residents (Gan et al., 2013), Atkinson et al. in a 
national cohort in UK with 812,063 subjects (Atkinson et al., 2015), and 
Schikowski et al. in 6,550 participants from ESCAPE cohorts (Schi-
kowski et al., 2014), found non-significant positive associations with 
COPD incidence (Table S1). Our study findings disagree with three 
studies that reported null associations (Carey et al., 2016; Fisher et al., 
2016; Salimi et al., 2018). An Australian study of 100,084 Sydney res-
idents observed negative associations of PM2.5 and NO2 with first hos-
pitalization of COPD (Salimi et al., 2018). In a study of 211,016 London 
residents, Carey et al. observed null associations of PM2.5 and NO2 with 
COPD incidence [general practitioner (GP) visit or hospital admission] 
(Carey et al., 2016), as did Fisher et al. between PM2.5 and COPD inci-
dence (self-reported physician-diagnosed COPD with subsequently re-
ported COPD diagnostic tests) in 121,701 female nurses from the US 
Nurses’ Health Study (Fisher et al., 2016). 
Our finding of a significant association of BC with COPD 
development is in agreement with the result by Gan et al. in the Cana-
dian study (Gan et al., 2013), which found a significant association of 5- 
year average exposure to BC with first COPD hospitalization (HR 1.06; 
1.02–1.09 per 0.97 10− 5m− 1), which remained unchanged after 
adjusting for PM2.5 and NO2. On the contrary, in the ESCAPE cohorts, 
Schikowski et al. found positive or negative, but not significant, asso-
ciations for BC using two different COPD definitions (Schikowski et al., 
2014). 
Only two studies investigated associations between long-term 
exposure to O3 and COPD incidence (Atkinson et al., 2015; Danesh 
Yazdi et al., 2019). In the national UK cohort, Atkinson et al. reported 
negative associations with COPD incidence, with HRs of 0.94 
(0.89–1.00) and 0.96 (0.90–1.02) per 3 μg/m3 increase in O3, based on 
GP records or hospital admissions, respectively (Atkinson et al., 2015). 
In contrast, in the South-western US, Danesh Yazdi et al. reported a 
positive association between annual average O3 and first COPD hospital 
admission, with a HR of 1.024 (1.023–1.025) per 1 ppb increase (Danesh 
Yazdi et al., 2019). In our study, we observed negative correlations 
between O3 and PM2.5/NO2/BC, related to the fine spatial scale model 
we used in a relatively small area. We also observed the null associations 
with O3 in single-pollutant models became significantly positive in two- 
pollutant models with NO2 or BC. Overall, our findings strengthen the 
evidence base by adding new results to support the notion that long-term 
exposure to air pollution may lead to the development of COPD. Traffic- 
related pollutants NO2 and BC may be the most relevant for COPD 
development. Results for the associations of BC and O3 exposures are 
much less investigated and inconclusive, calling for future studies on the 
potential roles of BC and O3 in COPD. 
Fig. 1. Distribution of the annual average of air pollution concentrations by sub-cohorts for the year 2010. The annual average concentrations of PM2.5, NO2, BC and 
O3 were estimated for the year 2010 at 100 m resolution. O3 was estimated during the warm season from April 1 through September 30. For PM2.5, red dotted lines 
indicate the annual average limited/guideline values of WHO (10 µg/m3), U.S. (12 µg/m3), and EU (25 µg/m3, exceed the maximum concentration of our study). For 
NO2, red dotted lines indicate the annual average limited/guideline values of WHO/EU (40 µg/m3), and WHO HRAPIE (health risks of air pollution in Europe) (20 
µg/m3). The bold lines in the middle of the box indicate the median values (50th percentiles). The lower and upper hinges correspond to the 25th and 75th per-
centiles. The lower and upper whisker extends to 5th and 95th percentiles. (For interpretation of the references to colour in this figure legend, the reader is referred to 
the web version of this article.) 
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Our findings of attenuated PM2.5 associations in the two-pollutant 
models with NO2 or BC, whereas the associations with NO2 and BC 
remained robust after adjustment for PM2.5, can be difficult to interpret 
and call for more research. Differential measurement error may 
complicate the interpretation of two-pollutant models (Butland et al., 
2019), as the pollutant with the lowest measurement error may show the 
most consistent association in two-pollutant models. Given that the 
correlation between PM2.5 and NO2 was moderate and the width of the 
confidence interval was only slightly increased in the two-pollutant 
models, we did not interpret the reduction of the HR for PM2.5 as 
merely an artefact related to multi-collinearity. The association with 
NO2 might reflect direct effects of NO2 or related particles emitted at 
combustion sources, such as BC and UFPs. Similarly, we did not interpret 
the reduction of the PM2.5 HR as implying that particles had no effect, as 
adjustment for NO2 also adjusted for particles from sources shared with 
NO2, including motorized traffic and other combustion sources. More 
data are needed to discern which air pollutants and sources are the most 
relevant for the development of COPD: total particle mass, combustion- 
related particles, or NO2. 
Limited representative toxicological studies provide mechanistic 
evidence for air pollution-related COPD development as most animal 
models replicate only a few COPD features and are time-consuming and 
technologically challenging (Huang et al., 2017; Jones et al., 2017). Air 
pollution induced oxidative stress and free radical reaction, which can 
trigger pulmonary and systemic inflammatory responses, are thought to 
be the plausible biological mechanisms behind the role of air pollution 
exposure in COPD development (Delfino et al., 2010; Hogg and van 
Eeden, 2009; Ling and van Eeden, 2009). Furthermore, airway remod-
elling related to repeated and intermittent air pollution exposures is 
likely a pathway to COPD development (Martinez, 2009); and a 
convincing number of studies on air pollution and accelerated decline in 
lung function can also shed light on the pathways (Guo et al., 2018; 
Lepeule et al., 2014; Rice et al., 2015; Wang et al., 2019). In effect 
modification, we observed slightly higher HRs with significant associa-
tions in current smokers, and no associations in never smokers. How-
ever, it should be noted that there was much smaller number of COPD 
cases in never smokers (398 out of 36,571) compared with current 
smokers (3,612 out of 32,295). Our observations of an enhanced asso-
ciation of PM2.5, NO2, and BC with COPD among participants < 65 years 
and married/divorced participants are novel. A study in Taiwan re-
ported no effect modification by BMI or smoking (Guo et al., 2018). The 
DCH cohort study found no effect modification between NO2 and COPD 
associations by BMI, smoking, or education (Andersen et al., 2011). The 
Toronto cohort reported a stronger association of NO2 with COPD in 
participants < 60 years, in line with our results (Weichenthal et al., 
2017), while the Vancouver cohort study did not observe effect modi-
fication by age for BC (Gan et al., 2013). Evidence therefore remains 
inconclusive on possible susceptibility of specific groups to the effects of 
air pollution on COPD development. 
This study has several strengths and limitations. We benefited from a 
large cohort obtained by pooling data from three Nordic cohorts with 
low levels of air pollution, objective definition of COPD incidence as first 
hospital discharge diagnosis, detailed information on relevant con-
founders, harmonized well-established air pollution models with data on 
a multiple major air pollutants, available complete history residential 
addresses of two cohorts for time-varying exposure calculation, and a 
long follow-up period. We contributed to the very limited studies on 
long-term exposure measures of BC and O3 in relation to COPD. The use 
of the first-ever hospital discharge diagnosis for COPD in hospital reg-
isters confers some degree of objective assessment, and studies have 
demonstrated the high specificity of COPD diagnoses using hospital 
registers in both Denmark (92% overall positive predictive rate) 
(Thomsen et al., 2011) and Sweden (<10% misclassification rate) 
(Inghammar et al., 2012), validating their use in epidemiology research. 
However, COPD is often undiagnosed for many years and not all patients 
with COPD are hospitalized, and therefore first-ever hospital discharge 
diagnoses may underrepresent the true COPD incidence. Additionally, it 
is difficult to separate COPD from asthma diagnosis and a part of COPD 
cases thus may in fact be asthma cases or mixed cases, which is another 
reason leading to underrepresentation of true COPD incidence. How-
ever, in our study, censoring occurred at the time of diagnoses of 
asthma, which could offset parts of the misclassification for first-ever 
Table 2 
Results of single- and two-pollutant models for the associations between long- 
term air pollution exposure and first-ever COPD hospitalization (N = 98,508).   
Single-pollutant models Two-pollutant models – based on Model 
3 
(Adjusted for pollutants below)  
Model 
1 
Model 
2 
Model 
3 
PM2.5 NO2 BC O3 
PM2.5 1.53 
(1.39, 
1.69) 
1.17 
(1.06, 
1.29) 
1.17 
(1.06, 
1.29) 
— 0.97 
(0.85, 
1.11) 
1.00 
(0.88, 
1.14) 
1.21 
(1.08, 
1.35) 
NO2 1.21 
(1.17, 
1.26) 
1.10 
(1.06, 
1.15) 
1.11 
(1.06, 
1.16) 
1.12 
(1.06, 
1.18) 
— 1.06 
(0.97, 
1.17)* 
1.16 
(1.11, 
1.23) 
BC 1.22 
(1.17, 
1.27) 
1.10 
(1.06, 
1.15) 
1.11 
(1.06, 
1.15) 
1.11 
(1.05, 
1.17) 
1.05 
(0.95, 
1.15)* 
— 1.15 
(1.09, 
1.20) 
O3 0.79 
(0.75, 
0.84) 
0.98 
(0.93, 
1.04) 
0.99 
(0.93, 
1.05) 
1.05 
(0.98, 
1.12) 
1.13 
(1.05, 
1.22) 
1.10 
(1.02, 
1.18) 
— 
Model 1 included age (time axis), sex (strata), study (strata), and calendar year 
of baseline; Model 2 further adjusted for smoking (status, duration, intensity, 
and intensity2), BMI (category), marital status, employment status and educa-
tion levels; Model 3 further adjusted for area-level mean year income, which is at 
municipality-level in 2001 for DCH and DNC and at neighbourhood level in 
1994 for CEANS. 
*: Two-pollutant result for NO2 and BC are difficult to interpret because of their 
high correlation. 
Results are presented as hazard ratio and 95% confidence interval [HR (95%CI)] 
for the following increments: 5 µg/m3 for PM2.5, 10 µg/m3 for NO2, 0.5 10− 5 m− 1 
for BC and 10 µg/m3 for O3. 
Table 3 
Results for the associations between long-term air pollution exposure and first- 
ever COPD hospitalization below various cut-off values in Model 3.  
Pollutants Concentration levels Number of observations HR (95%CI) 
PM2.5     
All levels 98,508 1.17 (1.06, 1.29)  
<25 µg/m3 98,508 1.17 (1.06, 1.29)  
<20 µg/m3 98,508 1.17 (1.06, 1.29)  
<15 µg/m3 86,433 1.23 (1.05, 1.44)  
<12 µg/m3 35,661 1.10 (0.71, 1.69)  
<10 µg/m3 20,842 1.46 (0.71, 3.01)  
NO2     
All levels 98,508 1.11 (1.06, 1.16)  
<40 µg/m3 96,657 1.12 (1.07, 1.17)  
<30 µg/m3 69,973 1.20 (1.11, 1.30)  
<20 µg/m3 28,144 1.06 (0.85, 1.33)  
BC     
All levels 98,508 1.11 (1.06, 1.15)  
<3 10− 5m− 1 98,501 1.11 (1.06, 1.15)  
<2.5 10− 5m− 1 98,423 1.11 (1.06, 1.16)  
<2 10− 5m− 1 97,179 1.11 (1.07, 1.16)  
<1.5 10− 5m− 1 74,929 1.16 (1.08, 1.25)  
<1 10− 5m− 1 34,707 1.19 (0.95, 1.51)  
<0.5 10− 5m− 1 4,904 3.81 (0.42, 34.95)  
O3     
All levels 98,508 0.99 (0.93, 1.05)  
<80 µg/m3 57,952 1.04 (0.95, 1.13)  
<60 µg/m3 60 — 
Results are presented for the following increments: 5 µg/m3 for PM2.5, 10 µg/m3 
for NO2, 0.5 10− 5 m− 1 for BC and 10 µg/m3 for O3. 
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COPD diagnoses. Rather, COPD hospital discharge diagnoses should not 
be regarded as onset of a disease but a hallmark of the progression of pre- 
existing COPD into a more severe stage. A Danish study found that the 
patients admitted acutely due to COPD exacerbation had a forced 
expiratory volume (FEV1) of approximately 30–40% of the predicted 
value, corresponding to the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) standard stages 3 and 4 (Eriksen et al., 2003). 
Thus, our study examines the onset of severe COPD, and likely repre-
sents older patients with a severe disease. One limitation of our study is 
the lack of lung function measurements and medical history in the co-
horts for verifying COPD diagnoses. We observed that the HRs for PM2.5, 
NO2, and BC were attenuated largely after adjustment for individual 
confounders including smoking, one of the most important risk factors 
for COPD. Nonetheless, we cannot exclude the possibility of some re-
sidual confounding by smoking, since we did not have more detailed 
history data on smoking duration and intensity. Similar to many cohort 
studies some weaknesses of this study includes exposure misclassifica-
tion, which is inherent when estimating air pollution levels at the resi-
dential address, and without information on air pollution levels at work, 
commuting habits, or personal time-activity patterns. Finally, our study 
lacked data on some potentially important confounders, such as physical 
activity, indoor air pollution and environmental tobacco smoking. 
5. Conclusion 
In this large study combining three European cohorts with access to 
data on hospital discharge diagnoses for COPD, long-term exposure to 
low levels of air pollution was associated with the development of 
COPD, even at levels below current EU and US limit values and possibly 
WHO guidelines. Associations with the traffic related air pollutants NO2 
and BC were most consistent. These results provide supports to the 
available evidence suggesting that further reductions in air pollution 
could help prevent new cases of COPD. 
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